Open Access Highly Accessed Research

A national internet-linked based database for pediatric interstitial lung diseases: the French network

Nadia Nathan1,2*, Rola A Taam3,4, Ralph Epaud5, Christophe Delacourt3,4, Antoine Deschildre6, Philippe Reix7, Raphaël Chiron8, Ulrika de Pontbriand9, Jacques Brouard10, Michaël Fayon11, Jean-Christophe Dubus12, Lisa Giovannini-Chami13, François Bremont14, Katia Bessaci15, Cyril Schweitzer16, Marie-Laure Dalphin17, Christophe Marguet18, Véronique Houdouin19, Françoise Troussier20, Anne Sardet21, Eglantine Hullo22, Isabelle Gibertini23, Malika Mahloul24, Delphine Michon1,24, Adrien Priouzeau24, Laurie Galeron1,2, Jean-François Vibert24, Guillaume Thouvenin1,2, Harriet Corvol1,2, Jacques deBlic3,4, Annick Clement1,2 and French RespiRare® Group

Author Affiliations

1 AP-HP, Hôpital Trousseau, Pediatric Pulmonary Department, Paris, F-75012, France

2 Université Pierre et Marie Curie-Paris6, Inserm, UMR S-U938, Paris, F-75012, France

3 Pediatric Pulmonary Department, AP-HP, Hôpital Necker Enfants Malades, Paris, F-75015, France

4 Université Paris Descartes-Paris5, Paris, F-75005, France

5 Centre Hospitalier Intercommunal de Créteil, Pediatric Department, Inserm U955, Université Paris Est, Créteil, France

6 Pediatric Department, Centre Hospitalier Universitaire de Lille, Lille, France

7 Pediatric Pulmonary Department, Centre Hospitalier Universitaire de Lyon, Lyon, France

8 Pediatric Pulmonary Department, Centre Hospitalier Universitaire de Montpellier, Montpellier, France

9 Pediatric Pulmonary Department, Centre Hospitalier Universitaire de Nantes, Nantes, France

10 Pediatric Department, Centre Hospitalier Universitaire de Caen, Caen, France

11 Pediatric Department, Centre Hospitalier Universitaire de Bordeaux, Département de Pédiatrie, Centre d'Investigation Clinique (CIC 0005), F-33000, Bordeaux, France

12 Pediatric Pulmonary Department, Centre Hospitalier Universitaire de Marseille, Marseille, France

13 Pediatric Department, Centre Hospitalier Universitaire de Nice, Nice, France

14 Pediatric Pulmonary Department, Centre Hospitalier Universitaire de Toulouse, Toulouse, France

15 Centre Hospitalier Universitaire de Reims, Reims, France

16 Pediatric Department, Centre Hospitalier Universitaire de Nancy, Nancy, France

17 Pediatric Department, Centre Hospitalier Universitaire de Besançon, Besançon, France

18 Pediatric Department, Centre Hospitalier Universitaire de Rouen, Rouen, France

19 Pediatric Pulmonary Department, Hôpital Robert Debré, Paris, F-75019, France

20 Pediatric Department, Centre Hospitalier Universitaire d’Angers, Angers, France

21 Pediatric Department, Centre Hospitalier de Lens, Lens, France

22 Pediatric Department, Centre Hospitalier Universitaire de Grenoble, Grenoble, France

23 Pediatric Department, Centre Hospitalier Universitaire de Tours, Tours, France

24 Inserm UMR S-707, Paris, F-75012, France

For all author emails, please log on.

Orphanet Journal of Rare Diseases 2012, 7:40 doi:10.1186/1750-1172-7-40

Published: 15 June 2012

Abstract

Background

Interstitial lung diseases (ILDs) in children represent a heterogeneous group of rare respiratory disorders that affect the lung parenchyma. After the launch of the French Reference Centre for Rare Lung Diseases (RespiRare®), we created a national network and a web-linked database to collect data on pediatric ILD.

Methods

Since 2008, the database has been set up in all RespiRare® centres. After patient's parents' oral consent is obtained, physicians enter the data of children with ILD: identity, social data and environmental data; specific aetiological diagnosis of the ILD if known, genetics, patient visits to the centre, and all medical examinations and tests done for the diagnosis and/or during follow up. Each participating centre has a free access to his own patients' data only, and cross-centre studies require mutual agreement. Physicians may use the system as a daily aid for patient care through a web-linked medical file, backed on this database.

Results

Data was collected for 205 cases of ILD. The M/F sex ratio was 0.9. Median age at diagnosis was 1.5 years old [0–16.9]. A specific aetiology was identified in 149 (72.7%) patients while 56 (27.3%) cases remain undiagnosed. Surfactant deficiencies and alveolar proteinosis, haemosiderosis, and sarcoidosis represent almost half of the diagnoses. Median length of follow-up is 2.9 years [0–17.2].

Conclusions

We introduce here the French network and the largest national database in pediatric ILDs. The diagnosis spectrum and the estimated incidence are consistent with other European databases. An important challenge will be to reduce the proportion of unclassified ILDs by a standardized diagnosis work-up. This database is a great opportunity to improve patient care and disease pathogenesis knowledge. A European network including physicians and European foundations is now emerging with the initial aim of devising a simplified European database/register as a first step to larger European studies.

Keywords:
Interstitial lung disease; Network; Epidemiology; Database